Frequentist rules for regulatory approval of subgroups in phase III trials: A fresh look at an old problem. - Edgar, K; Jackson, D; Rhodes, K; Duffy, T; Burman, C-F; Sharples, LD (Statistical Methods in Medical Research, 2021)